Independent Medical Education from COR2ED developed by GU NURSES CONNECT, experts in GenitoUrinary (GU) oncology nursing. https://xitter.cf/t.co/PchtPfFT3b
Joined August 2020
- Tweets1K
- Following564
- Followers607
- Likes1.8K
GU NURSES CONNECT powered by COR2ED retweeted
📣GU update from #ESMO26!
Dr @DrIacovelli joined us at ESMO to share his views on #prostatecancer & #bladder cancer highlights from the meeting
Will updated OS results from CAPItello-281, and phase 3 data from DASL-HiCaP; ANZUP1801 & VOLGA trials impact clinical practice?
Watch the video to find out!
🤝Programme endorsed by @WarOnCancer
📺Get the abstract details & see more updates from @myESMO in #gastriccancer, #crc, #pancreaticcancer, #HCC, #breastcancer & #NSCLC:
cor2ed.com/n-connect/program…
This educational programme is supported by COR2ED. For HCPs only.
#MedEd #OncTwitter #MedTwitter #PCSM
GU NURSES CONNECT powered by COR2ED retweeted
Check out our Collaborators at COR2ED and this EXPERT insights from #ESMO26
GI oncologists Dr Lizzy Smyth, Dr Yelena Janjigian and Assoc. Prof. Gerald Prager join COR2ED at ESMO 2026 to provide their instant reactions on new data presented at the meeting. While Drs Smyth and Janjigian discuss gastric/GEJ cancer developments, Dr Prager will be focusing on colorectal and pancreatic cancer. @LizzySmyth1, @YJanjigianMD
cor2ed.com/esmo-2026/gastric…
GU NURSES CONNECT powered by COR2ED retweeted
🎙️ ESMO 2026: Expert insights in NSCLC
Our Collaborators at @COR2EDMedEd met with medical oncologist Dr Louise Lim at ESMO 2026 , to discuss the latest non-small cell lung cancer (NSCLC) data and what it could mean for clinical practice. 👉 cor2ed.com/highlights-from-e…
🔬 Key studies in focus:
▪️ KRAS G12C: KRAScendo 1 (LBA5)
▪️ EGFR-mutated, MET-driven NSCLC: SAFFRON (LBA6)
▪️ First-line PD-L1-negative NSCLC: OptiTROP-Lung06 (LBA66)
▪️ EGFR-mutated NSCLC post-TKI: OptiTROP-Lung04 (LBA67)
Join us for expert perspectives on these emerging data and their potential implications for treatment decisions.📍 Recorded at ESMO 2026
#ESMO26 #LungCancer
GU NURSES CONNECT powered by COR2ED retweeted
🎥 #ESMO26 highlights from our collaborators @COR2EDMedEd Visit them at the main exhibition hall to learn more
Watch Here👉 buff.ly/HBEGYqU
Leading experts give quick takes on the key data, ~3 min per tumour type:
🔹 Gastric/GEJ: Smyth & Janjigian
🔹 CRC & pancreatic: Prager
🔹 HCC: Chon & Rimassa
🔹 NSCLC: Newsom-Davis & Lim
🔹 Breast: Jhaveri
🔹 GU: Iacovelli
@YJanjigianMD, @tnewsomdavis, @LorenzaRimassa, @jhaveri_komal, @DrIacovelli @COR2EDMedEd
GU NURSES CONNECT powered by COR2ED retweeted
Drs @jhaveri_komal and @DrIacovelli are joining our collaborators at COR2ED at ESMO 2026 to share their thoughts on the latest data presented at the meeting. Dr Jhaveri will provide insights on #BreastCancer 🇺🇸 data, while Dr Iacovelli 🇮🇹 will review developments in #ProstateCancer and #BladderCancer
👉 Explore the coverage cor2ed.com/highlights-from-e…
GU NURSES CONNECT powered by COR2ED retweeted
📣 Update from #ASCO26!
Renowned experts share their views on new data emerging from the @ASCO Annual Meeting
👉 𝘏𝘌𝘙2-mutant NSCLC:
Dr @herbloong & Dr @ipreeshagul data from SOHO-01, PRO data from Beamion LUNG-1, and more
~Endorsed by @WarOnCancer, @BiomarkerCo, @Exon20Group & @isliquidbiopsy
(📺Video in this post! Slides also available: cor2ed.com/n-connect/program…)
👉 #NSCLC:
Prof. @MarkSocinski reviews #LungCancer data from #LIBRETTO-432, WU-KONG28 & #HARMONi-6
~Endorsed by International Cancer Advocacy Network, Biomarker Collaborative, Exon20 Group & International Society of Liquid Biopsy
👉 #ProstateCancer:
Prof. Evan Yu reviews data from #PROTEUS & #TALAPRO-3
~Endorsed by International Cancer Advocacy Network
👉 #ColorectalCancer, #PancreaticCancer & #LiverCancer:
Prof. @HPrenen reviews data from #RASolute 302, #BREAKWATER & #EMERALD-3
~Endorsed by International Cancer Advocacy Network & @dice_europe
👉 #BreastCancer:
Dr @PtarantinoMD reviews data from #ASCENT-03, ASCENT-04, #TROPION-Breast02, #SERENA-6, #VIKTORIA-1, & #OPTIMA
~Endorsed by International Cancer Advocacy Network
How will these data impact clinical practice? Watch the videos to find out!
▶️ cor2ed.com/n-connect/program…
𝘏𝘌𝘙2-mutant NSCLC update supported by an Independent Educational Grant from Bayer. All other updates supported by COR2ED.
#MedEd #OncTwitter #MedTwitter #Oncology
GU NURSES CONNECT powered by COR2ED retweeted
Get expert insights on the latest data in lung, prostate, GI, and breast cancers presented at #ASCO26 . Renowned medical experts join @COR2EDMedEd in Chicago to share their views on data emerging from the meeting. How will new trial data impact clinical practice? Watch the video updates to find out!
buff.ly/eQiz2b7
@herbloong
@ipreeshagul
@PTarantinoMD
GU NURSES CONNECT powered by COR2ED retweeted
Lung cancer 🫁 update from #ASCO26
👉 buff.ly/9P3rYdv
Renowned lung cancer experts join our collaborators at COR2ED at ASCO 2026 to discuss breaking data emerging from the meeting. Watch the video updates for insights on HER2-mutant non-small cell lung cancer (NSCLC) from Drs Herbert Loong and Isabel Preeshagul, and analysis of other key lung cancer trial data from Prof. Mark Socinski.
#LungCancer #NSCLC #SCLC
@herbloong @ipreeshagul
GU NURSES CONNECT powered by COR2ED retweeted
📣#GUCancer highlights from #ASCO26!
Medical Oncologist Prof. Evan Yu shares his expert insights on key #ProstateCancer #trialdata from #PROTEUS & #TALAPRO-3
How will these data impact clinical practice? Watch his video to find out!
🤝 Programme endorsed by @WarOnCancer
📺See more updates from @ASCO in #HER2-mutant #NSCLC, #LungCancer, #GIcancer & #BreastCancer
⬇️
cor2ed.com/n-connect/program…
This educational programme is supported by COR2ED
#MedEd #PCSM #urology #CancerNurses #OncTwittter #crpc
GU NURSES CONNECT powered by COR2ED retweeted
GI and hepatobiliary cancer update from ASCO 2026
Medical oncologist Prof. Hans Prenen joins @COR2EDMedEd in Chicago to share his expert insights on the latest data in colorectal, pancreatic, and liver cancers presented at ASCO 2026. How will late-breaking data impact clinical practice? Watch his video update to find out.
buff.ly/dSEZYZp
GU NURSES CONNECT powered by COR2ED retweeted
Breast Cancer Update from ASCO 2026 : Watch Dr @PTarantinoMD joins @COR2EDMedEd in Chicago to share his views on the latest breast cancer data emerging from ASCO 2026. How will new developments impact clinical practice? Watch his update to find out!
buff.ly/iLLs16U
GU NURSES CONNECT powered by COR2ED retweeted
Dear Colleagues at #ASCO26
Get expert insights on new #ProstateCancer data emerging from ASCO 2026. Prof. Evan Yu joins @COR2EDMedEd live in Chicago to share his views on how new trial data presented at the meeting could impact the clinical management of patients with prostate cancer. Watch his conference update now.
Watch here👉 cor2ed.com/asco-2026/prostat…
📣#GUCancer highlights from #ASCO26!
Medical Oncologist Prof. Evan Yu shares his expert insights on key #ProstateCancer #trialdata from #PROTEUS & #TALAPRO-3
How will these data impact clinical practice? Watch his video to find out!
🤝 Programme endorsed by @WarOnCancer
📺See more updates from @ASCO in #HER2-mutant #NSCLC, #LungCancer, #GIcancer & #BreastCancer
⬇️
cor2ed.com/n-connect/program…
This educational programme is supported by COR2ED
#MedEd #PCSM #urology #CancerNurses #OncTwittter #crpc
GU NURSES CONNECT powered by COR2ED retweeted
Lung cancer 🫁 update from #ASCO26
👉 buff.ly/aQLvoj5
Renowned lung cancer experts join our collaborators at @COR2EDMedEd at ASCO 2026 to discuss breaking data emerging from the meeting. Watch the video updates for insights on HER2-mutant non-small cell lung cancer (NSCLC) from Drs Herbert Loong and Isabel Preeshagul, and analysis of other key lung cancer trial data from Prof. Mark Socinski.
#LungCancer #NSCLC #SCLC
@herbloong @ipreeshagul
GU NURSES CONNECT powered by COR2ED retweeted
📢 #ASCO26 is nearly here, keep a look out for our conference update!
In this video, Dr @ipreeshagul introduces the medical experts who will be joining us at ASCO
➡️Dr @herbloong: 𝘏𝘌𝘙2-mutant NSCLC (along with Dr Preeshagul)
➡️Prof. @MarkSocinski: #NSCLC / #LungCancer
➡️Prof. Evan Yu: #ProstateCancer
➡️Prof. @HPrenen: #GIcancer: #HCC, #LiverCancer, #CRC, #PanCan
➡️ Dr @PTarantinoMD: #BreastCancer
🎬 Keep checking back to see the videos as soon as they’re released: cor2ed.com/n-connect/program…
𝘏𝘌𝘙2-mutant NSCLC update supported by an Independent Educational Grant from Bayer. All other updates supported by COR2ED
#MedEd #OncTwitter #OncMedEd
May is #OncologyNursingMonth
We want to recognise #cancernurses around the world, working tirelessly to provide the best care for their patients
Thank you for all you do! 💐
From @COR2EDMedED, @ginursesconnect and GU NURSES CONNECT
#IND26 #OncologyNursing
Recap from #ESMO25: Prof. Viktor Grünwald discusses emerging data in advanced renal cell carcinoma and potential implications for clinical practice.
Watch the video covering LenCabo, KEYMAKER-U03, CLEAR & [68 Ga]Ga-DPI-4452 (CAIX) imaging here : cor2ed.com/n-connect/program…
#MedEd #GUOncology
This programme is financially supported by an independent educational grant from Eisai Europe Limited. Eisai has financially contributed towards this material as a sponsor and has had no influence in its organisation or creation.
Check out this interactive patient case with clear takeaways for managing early treatment intensification for mCRPC patients in routine practice
#MedEd
Do you treat pts w/ mCRPC and know when to consider early treatment intensification?
📺 Patient case video and ‘SHARE’ communication framework for you to use in your clinical practice
>> From Uro-Oncologist Prof. Gunhild von Amsberg
PART 2 OF THE HIGHLIGHTS VIDEO IN THIS POST!
Check out Part 1 in our previous post 👀
~ Endorsed by Urobel & @ZEROCancer ~
Supported by an Independent Educational Grant from AstraZeneca
#MedEd #PCSM
Prof. Viktor Grünwald shares key insights from ESMO 2025 on emerging data in advanced renal cell carcinoma.
Highlights include evolving first- and later-line strategies, triplet regimens, and tumour-specific imaging in clear cell RCC.
Watch the full video update on YouTube here:
youtube.com/watch?v=KTVQvYkZ…
#RCC #RenalOncology #MedEd
Supported by an independent educational grant from Eisai Europe Limited.
